Activation of BAD by Therapeutic Inhibition of Epidermal Growth Factor Receptor and Transactivation by Insulin-like Growth Factor Receptor
Open Access
- 1 August 2002
- journal article
- Published by Elsevier
- Vol. 277 (31), 27643-27650
- https://doi.org/10.1074/jbc.m108863200
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Anti-apoptotic Signaling of the Insulin-like Growth Factor-I Receptor through Mitochondrial Translocation of c-Raf and Nedd4Journal of Biological Chemistry, 2001
- Stimulation of the Mitogen-activated Protein Kinase Cascade and Tyrosine Phosphorylation of the Epidermal Growth Factor Receptor by HepatopoietinPublished by Elsevier ,2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Growth Factors Inactivate the Cell Death Promoter BAD by Phosphorylation of Its BH3 Domain on Ser155Journal of Biological Chemistry, 2000
- NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- The Hallmarks of CancerCell, 2000
- ZD1839 (???Iressa???)*,??? as an Anticancer AgentDrugs, 2000
- Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathwayOncogene, 1999
- Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolinesBreast Cancer Research and Treatment, 1996
- The IRS-1 signaling systemTrends in Biochemical Sciences, 1994